Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Year-over-year net income growth rate
Percentile
P26
Within normal range
vs 3Y Ago
-9.8x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -63.70% |
| Q2 2025 | -149.50% |
| Q1 2025 | -351.19% |
| Q4 2024 | 147.44% |
| Q3 2024 | -160.99% |
| Q2 2024 | 135.91% |
| Q1 2024 | -26.07% |
| Q4 2023 | 36.31% |
| Q3 2023 | -778.52% |
| Q2 2023 | 75.52% |
| Q1 2023 | -40.49% |
| Q4 2022 | -19.74% |
| Q3 2022 | 6.52% |
| Q2 2022 | -5.03% |
| Q1 2022 | -45.10% |
| Q4 2021 | -11.59% |
| Q3 2021 | 12.51% |
| Q2 2021 | -12.72% |
| Q1 2021 | 17.04% |
| Q4 2020 | -14.82% |
| Q3 2020 | -22.48% |
| Q2 2020 | 7.25% |
| Q1 2020 | -10.73% |
| Q4 2019 | 34.06% |
| Q3 2019 | -65.63% |
| Q2 2019 | -16.09% |
| Q1 2019 | 16.27% |
| Q4 2018 | -168.99% |
| Q3 2018 | 47.34% |
| Q2 2018 | 2.68% |
| Q1 2018 | -33.25% |
| Q4 2017 | -201.93% |
| Q3 2017 | 87.94% |
| Q2 2017 | -99.04% |
| Q1 2017 | 65.83% |
| Q4 2016 | -300.00% |
| Q3 2016 | 38.33% |
| Q2 2016 | -23.75% |
| Q1 2016 | -39.49% |
| Q4 2015 | -141.02% |